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Background: In general, smoking increases the risk of mortality. However, it is less 
clear which specific cause of death is associated with the highest risk. The exact 
impact of changes in smoking habits throughout life on different mortality risks is 
less studied. 
Methods: We studied the impact of baseline and lifetime smoking habits, and 
duration of smoking on the risk of all-cause mortality, mortality of cardiovascular 
diseases (CVD), any cancer and of the four most common types of cancer (lung, 
colorectal, prostate, and breast cancer) in a large cohort study (Vlagtwedde-
Vlaardingen 1965-1990, with a follow-up on mortality status until 2009, n = 8,645). 
We used Cox regression models adjusted for age, BMI, sex, and place of residence. 
Since previous studies suggested a potential effect modification of sex, we 
additionally stratified by sex and tested for interactions. In addition, to determine 
which cause of death carried the highest risk we performed competing-risk analyses 
on mortality due to cancer, CVD and other causes. 
Results: Current smoking (light, moderate, and heavy cigarette smoking) and 
lifetime persistent smoking were associated with an increased risk of all-cause, CVD, 
any cancer, and lung cancer mortality. The effect of smoking on the risk of lung 
cancer mortality was different for males and females; the effect was more 
pronounced in females. Higher numbers of pack years at baseline were associated 
with an increased risk of all-cause, any cancer, lung, colorectal, and prostate cancer 
and CVD mortality. Males who were lifetime persistent pipe/cigar smokers had a 
higher risk of lung cancer [Hazard Ratio (95% CI) = 7.72 (1.72-34.75)] as well as all-
cause and any cancer mortality. A longer duration of smoking was associated with a 
higher risk of any and lung cancer [HR (95% CI) = 1.03 (1.00-1.06) and 1.10 (1.03-1.17) 
respectively], but not with other mortality causes. The competing risk analyses 
showed that ex- and current smokers had a higher risk of both cancer and CVD 
mortality compared to all other mortality causes. In addition, heavy smokers had a 
higher risk for cancer mortality compared to CVD mortality. 
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Conclusion: Our study indicates that lifetime numbers of cigarettes smoked and the 
duration of smoking has different impact for different causes of mortality and for 
males and females. Moreover, our findings emphasize on the importance of 
smoking-related competing risks when studying the smoking-related cancer 
mortality in a general population and that smoking cessation immediately effectively 






Tobacco smoking has been clearly linked to the most common causes of death 
including cancer and cardiovascular disease (CVD) (1-3). The association between 
cigarette smoking and the development of these diseases has mainly been explained 
by the fact that smoking causes a systemic oxidant-antioxidant imbalance and an 
inflammatory response (4). 
Since 1950, several studies have shown that tobacco smoking is associated with an 
increased risk of lung cancer (5). In the first International Agency for Research on 
Cancer (IARC) Monograph on tobacco smoking in 1986, not only lung cancer but 
also some other types of cancer including cancer of upper aerodigestive tract, 
pancreas, and lower urinary tract were reported to be associated with smoking (6). 
Further studies on the association between smoking and different types of cancers 
added more cancer types to this list. In the second IARC Monograph on tobacco 
smoking of 2004 (7) and the last monograph of 2012 (8), 14 other types of cancer 
were listed as smoking-related cancers, e.g. cancers of the oral cavity, nasal cavity, 
stomach, liver, kidney, cervix and myeloid leukemia. However, for some other types 
of cancer such as prostate and breast cancer still no conclusion on their association 
with smoking could be drawn across the studies. 
Most importantly, like for cancer, tobacco smoking is reported to cause nearly 10% of 
CVD worldwide (9). Several prospective cohort studies have addressed the 
beneficial effect of smoking cessation on CVD mortality (9). 
Several studies have indicated that the association between smoking and mortality 
appears to be different for different causes of death such as cancer and CVD (10). 
However, the differences in this association with smoking between various causes of 
death (e.g. cancer and CVD) have not been formally analyzed using statistical 
approaches such as competing risk analyses. So far, the only previous study that 
statistically analyzed these differences was performed solely on females (10). 
Moreover, in the majority of previous studies the level of detail on lifetime smoking 
history (e.g. regarding duration of smoking and cessation) is limited, and results 
remain inconclusive. For instance, Vineis et al (11) in a review reported that the 
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beneficial effect of smoking cessation is the same for smoking-related cancer and 
non-neoplastic disease, while Kenfield et al (10) suggested that benefits of smoking 
cessation vary by causes of death. Thus, more prospective investigations are needed 
to determine the lifetime smoking-attributable risk of cause-specific mortality. 
 In addition, evidence shows conflicting results for the potential role of sex in the 
association between smoking and mortality (11). For instance, while the majority of 
studies indicated that females may be more susceptible to the carcinogenic effects of 
smoking, a recent study by Kovalchik et al (13) in an Italian population, reports that 
the risk of lung cancer, among 30 pack-year smokers, is lower in females than males. 
Although smoking cigarettes is the most common form of tobacco usage, pipe/cigar 
smoking also accounts for a considerable proportion of tobacco smokers in some 
countries. For instance, in the European Prospective Investigation into Cancer (EPIC) 
study of 500,000 subjects across 10 countries, more than 3,500 males were exclusively 
pipe/cigar smokers, and 15,000 males smoked pipe/cigar in addition to cigarettes 
(14). The EPIC study conﬁrmed that pipe and cigar smoking are related to some 
cancer types such as lung, bladder, and colon cancer. So far, the relation of 
pipe/cigar smoking with cause-specific mortality is not as clear as that of cigarette 
smoking with cause-specific mortality. For instance, Tverdal et al (15) found no or 
only minor differences in the cause-specific mortality risk between pipe smokers and 
cigarette smokers and reported that both are associated with an increased risk of 
mortality. Another study showed that pipe/cigar smokers have a lower risk for 
mortality compared with cigarette smokers (16).  
We therefore aimed to examine the impact of baseline and lifetime smoking habits, 
lifetime duration of smoking and duration of smoking cessation on risk of all-cause 
mortality, CVD mortality and mortality due to any cancer and the four most 
common types of cancer, i.e. lung, colorectal, prostate, and breast cancer. We used 
the Vlagtwedde-Vlaardingen cohort study (17,18), a large population-based cohort 
with  follow-up for 43 years which offered the unique possibility to investigate the 
impact of lifetime smoking habits on the risk of mortality. To shed more light on the 
role of sex, we additionally assessed whether the association between smoking 
habits and mortality risk is different for males and females. Other objectives of this 
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study were to assess the association of pipe/cigar smoking for mortality risk and to 
determine which cause of death carried the highest risk by performing a competing-





We investigated the association between lifetime smoking habits and risk of 
mortality using the Vlagtwedde-Vlaardingen cohort study. The Vlagtwedde-
Vlaardingen study is a general population based study on the epidemiology of 
pulmonary diseases in a general population of exclusively white individuals of 
Dutch descent (17,18). The study started in 1965 and participants had medical 
examinations every 3 years until the final survey in 1989/1990. In Vlaardingen, only 
participants who were included at baseline (1965 or 1969) were approached for 
follow-up, whereas in Vlagtwedde new subjects aged between 20 and 65 years were 
invited to participate at every survey. The number of surveys per subject ranged 
from one to eight (median number of surveys per subject: five). We updated the vital 
status of all participants in the Vlagtwedde-Vlaardingen study on December 31st, 
2008, and evaluated the following mortality outcomes: all-cause mortality, CVD 
mortality, any cancer mortality, and mortality due to four common types of cancer 
i.e. lung cancer, colorectal cancer, prostate cancer and breast cancer, either as 
primary or secondary cause of death. Causes of death were coded according to the 
International Classification of Diseases (ICD) (see supplementary table 1 for the used 
ICD-codes) and obtained from Statistics Netherlands (The Hague).  
 
Population characteristics 
At all surveys, we collected data on age, sex, and smoking habits using the Dutch 
version of the British Medical Research Council questionnaire (17,18). The BMI (body 
mass index) was calculated as weight in kilograms divided by the square of the 
height in meters (kg/m2).   
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Smoking habits at baseline 
We categorized the smoking habits at baseline (i.e. the first available survey of  
a subject) into three different categories:  
1) Never smokers: subjects who reported never to have smoked during their entire 
life;  
2) Ex-smokers: subjects who had stopped smoking at least one month before the 
baseline survey;  
3) Current smokers: subjects who smoked at least one cigarette a day. Current 
smokers were divided into light (<10 cig/day), moderate (10-20 cig/day) and heavy 
cigarette smokers (>20 cig/day) and pipe/cigar smokers (only among males).  
Pack-years at baseline were defined as the number of packs of cigarettes (1 pack = 20 
cigarettes) smoked per day in one year.  
 
Lifetime smoking habits 
Lifetime smoking habits were determined if subjects participated in at least three 
surveys. We defined lifetime smoking habits within the interval between the 
baseline survey and the last available survey as follows:  
1) Never smokers: subjects who reported no smoking history at baseline and 
remained non-smokers during the interval; 
2) Ex-smokers: subjects who were ex-smokers at baseline and remained ex-smokers 
during the interval; 
3) Quitters: subjects who were current smokers (cigarette or pipe/cigar) at baseline 
but successfully quitted smoking during the interval; 
4) Persistent smokers: subjects who were current smokers (cigarette or pipe/cigar) at 
baseline and remained smokers during the interval. Persistent male smokers were 
further divided into exclusively cigarette smokers, exclusively pipe/cigar smokers, 
and mixed product smokers (i.e. subjects who smoked pipe/cigar one survey and 
cigarettes another survey);    




Duration of smoking and duration of smoking cessation 
We calculated the duration of smoking as the difference between the age at starting 
smoking and the age at last survey (for persistent smokers) or the age at quitting 
smoking (for ex-smokers and quitters). We calculated the duration of smoking 




Descriptive analyses of the subject characteristics and the mortality statistics were 
performed. Independent sample t-tests, Mann-Whitney U tests, or Chi-square tests 
were used to determine significant differences between groups for continuous and 
categorical variables, respectively. Multivariate Cox regression with adjustment for 
age, BMI (at baseline for the analyses on baseline smoking habits and at last survey 
for all other analyses), sex, and place of residence were used to estimate the effect of 
the different smoking habits on the mortality outcomes. Since data on pipe/cigar 
smoking was available only in males, in the analyses on all subjects we excluded 
pipe/cigar smokers. To determine whether the association between smoking habits 
and mortality was different for males and females, stratified analyses were 
performed and interactions between smoking and sex were tested. To investigate the 
difference between the never smokers and all other smoking groups we used the 
never smokers as our reference. In addition, in the analysis on baseline smoking 
habits we also performed an analysis with the ex-smokers as the reference group in 
order to investigate the differences between the ex-smokers and the current smokers. 
In the analysis on lifetime smoking habits we also performed an analysis with the 
persistent smokers as a reference in order to investigate the differences between the 
persistent smokers and the ex-smokers and quitters. Two separate analyses on 
pipe/cigar smoking at baseline and during lifetime were performed in males only. 
In these analyses pipe/cigar smoking was taken as the reference group. In the 
analyses on lifetime smoking, both duration of smoking and duration of smoking 
cessation were entered in one model. In the Cox regression analyses censoring took 
place when the subjects were still alive, were lost to follow-up, or died from a cause 
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other than the one of interest. The external causes of death (i.e. suicides, homicides, 
traffic accidents etc.) were excluded from the analyses, (ICD-9: codes ≥800 and in 
ICD-10: codes ≥S00). For the analyses on baseline smoking habits, time was defined 
as years from baseline until mortality or until censoring. For the analyses on lifetime 
smoking habits, time was defined as years from last survey until mortality or until 
censoring. Finally, we performed a competing-risk analysis on CVD mortality, 
cancer mortality, and other mortality (19). All analyses were performed at Statistics 
Netherlands (The Hague, the Netherlands). P-values <0.05 (two-sided) were 





Characteristics of the subjects according to vital status on December 31st 2008 are 
presented in table 1. Among all 8,465 subjects, 4,505 (53.2%) were alive, 3,675 (43.4%) 
died due to all-cause mortality (excluding external causes), 150 subjects (1.8%) died 
due to external causes such as an accident, suicide or homicide. In 13 (0.1%) subjects 
the cause of death could not be determined, and 122 (1.5%) subjects were lost to 
follow-up. Of those subjects who died, 1,882 (51.3%) died due to CVD, 1,194 (32.6%) 
died due to cancer (147 subjects were coded for both cancer and CVD), and 746 
(8.8%) died due to another cause than CVD or cancer. Of those subjects who died 
due to cancer, 275 (23.0%) died due to lung cancer, 134 (11.2%) died due to colorectal 
cancer, 83 (7.0%) died due to prostate cancer, and 117 (9.9%) died due to breast 
cancer. 
The mean age at the first survey of the subjects who died due to CVD was 50.2 (SD = 
9.6) years, and 56.9% were males. The mean age at the first survey of the subjects 
who died due to cancer during follow-up was 45.9 (standard deviation (SD) = 11.1) 
years, and 58.3% were males. Subjects who died due to cancer had significantly 
higher BMI levels at the first survey compared to subjects who were alive, but had  
a lower BMI compared to subjects who died due to CVD. Subjects who died due to 
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cancer were more often heavy smokers (21.3 %) compared to subjects who were alive 
or died due to CVD or causes other than cancer (table 1).   
Among all 8,465 subjects, 7,361 (87.0 %) subjects had data available on baseline 
smoking habits and on all included covariates, 7,075 (83.6 %) subjects had data 
available on cigarette smoking and 286 (3.4 %) males had data available on 
pipe/cigar smoking). In total, 4,325 (51.1 %) subjects were ever smokers and had 
data on pack-years and on all included covariates, and for 3,925 (46.4 %) subjects, 
data on lifetime changes in smoking habits and on all included covariates could be 
obtained (supplementary table 2-4).  
 
Baseline smoking habits  
Table 2 shows the hazard ratios (with 95% confidence intervals (CI)) of smoking 
habits at baseline for mortality. Ex-smoking and current smoking (light, moderate, 
and heavy cigarette smoking) subjects had a  higher risk of all-cause mortality, and 
mortality to any cancer and lung cancer, compared to never smokers, the hazard 
ratios being highest for heavy smokers. The same pattern was observed for mortality 
due to CVD. No significant associations were found between smoking habits at 
baseline and risk of colorectal cancer, prostate cancer and breast cancer mortality 
(table 2). The analysis with the ex-smokers as the reference showed that light 
smoking is not associated with a higher risk of all-cause or cause specific mortality 
compared to ex-smokers (supplementary table 5). 
There was significant interaction between light cigarette smoking and sex on risk of 
mortality due to lung cancer (HR: 0.21 (0.07-0.62)); the effect was more pronounced 
in females. No significant interactions were observed between smoking and sex on 
risk of all-cause, CVD, any cancer, or colorectal cancer mortality (table 2). 
The competing risk analyses showed that ex- and current smokers had a higher risk 
of both CVD and cancer mortality compared to all other mortality causes. In 
addition, heavy smokers had a higher risk for cancer mortality compared to CVD or 
other causes of death (supplementary table 6). 
Within ever smokers, a higher number of pack years was associated with an 
increased risk of all-cause, CVD, any cancer and lung cancer, and prostate cancer 
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mortality. A higher number of pack years was associated with an increased risk of 
colorectal cancer mortality only among females (HR: 1.08 (95% CI: 1.04-1.11)). There 
were no significant associations between pack years and risk of mortality due to 
breast cancer (table 2). The numbers of pack years significantly interacted with sex 
on risk of mortality due to lung cancer (HR: 0.96 (0.94-0.99)), and colorectal cancer 
(HR: 0.93 (0.90-0.96)); effects were more pronounced in females (table 2).  
 
Lifetime (changes in) smoking habits  
Table 3 shows the hazard ratio (with 95% confidence interval) of lifetime smoking 
habits for mortality. Persistent cigarette smokers had a higher risk to die of all-
causes, CVD, any cancer, and lung cancer compared to never smokers. Subjects who 
quitted smoking during follow-up had a higher risk to die of lung cancer compared 
to never smokers (HR: 3.65 (95% CI: 1.32-10.10). The analysis with the persistent 
cigarette smokers as the reference showed that never smokers, persistent ex-
smokers, quitters, and unstructured smokers had a lower risk to die of all-cause, 
CVD, any cancer, and lung cancer (supplementary table 7). 
There were no significant associations between lifetime smoking habits and risk of 
mortality due to colorectal cancer, prostate cancer, or breast cancer (table 3). There 
were no significant interactions between lifetime persistent cigarette smoking and 
sex on risk of all-cause, or cause specific mortality. The competing risk analyses 
showed that males who were lifetime persistent smokers had a higher risk of CVD 
and cancer mortality compared to other mortality causes (supplementary table 8). 
 
Pipe/cigar smoking 
Table 4 shows the hazard ratios (with 95% confidence intervals) of smoking habits 
for mortality among males. Males who were never smoker at baseline had a lower 
risk to die of all-cause, CVD, and any cancer compared to pipe/cigar smokers. Males 
who were heavy or moderate smokers had a higher risk to die of all-cause, CVD, any 
cancer, and lung cancer compared to pipe/cigar smokers. Lifetime persistent ex-
smokers had a lower risk to die of lung cancer compared to pipe/cigar smokers (HR: 
0.12 (95% CI: 0.03-0.55)).  
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Lifetime duration of smoking and duration of smoking cessation 
A longer lifetime duration of smoking was associated with a higher risk of mortality 
from any cancer and from lung cancer (any cancer: HR: 1.03 (95% CI: 1.00-1.06), and 
lung cancer: HR: 1.10 (95% CI: 1.03-1.17)), but not with other causes of death  
(table 5). There was a significant interaction between duration of smoking and sex on 
the risk of mortality due to colorectal cancer (HR: 0.91 (0.83-0.99)); the effect was 
stronger in females (table 5). 
A longer duration of smoking cessation was associated with a lower risk of all-cause 
mortality (HR: 0.98 (95% CI: 0.96-0.99)), and CVD (HR: 0.97 (95% CI: 0.95-1.00) (table 
5). No significant interactions were found between duration of smoking cessation 




In this large cohort study we investigated the impact of baseline cigarette and 
pipe/cigar smoking, pack-years, and lifetime smoking history on the risk of all-cause 
mortality and cause-specific mortality (i.e. CVD and cancer mortality) in both sexes. 
Current smoking (light, moderate, and heavy cigarette smoking), and lifetime 
persistent smoking were associated with an increased risk of all-cause mortality, 
mortality due to CVD, any cancer and lung cancer. A higher number of pack years at 
baseline was associated with an increased risk of all-cause mortality, CVD, any 
cancer mortality, lung cancer and prostate cancer mortality. The effect of smoking on 
the risk of lung cancer mortality was different for males and females; the effect was 
more pronounced in females. Moreover, significant interactions between light 
cigarette smoking and sex, and pack years and sex on risk of mortality due to lung 
cancer were observed. A longer duration of smoking was associated with an 
increased risk of mortality due to any cancer and lung cancer, but not with other 
causes of death. A longer duration of smoking cessation was associated with a 
decreased risk of all-cause and any cancer mortality. The competing risk analyses 
showed that ex- and current smokers had a higher risk of both CVD and cancer 
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mortality compared to all other mortality causes. In addition, heavy smokers had  
a higher risk for cancer mortality compared to CVD. 
Our results are in line with the conclusion of the recent review by IARC (8) and other 
studies (10,20). In addition, it helps to expand and clarify the links between smoking 
and common types of cancer and other causes of mortality in both sexes.  
Lung cancer has been clearly linked to smoking (21,22). However, little is known 
about lifetime smoking habits such as duration of smoking and duration of smoking 
cessation on lung cancer mortality. We found that longer lifetime duration of 
cigarette smoking is associated with an increased risk of lung cancer mortality 
among persistent smokers, ex-smokers and quitters. We found no significant 
association between duration of smoking cessation and risk of mortality due to lung 
cancer; however, a negative trend was observed.  So far, previous studies have 
shown inconsistent results for the association between smoking cessation and lung 
cancer. While the majority of studies showed a negative association, there are also 
some indications there is no association (23). The inconsistent results among studies 
may be partially explained by the fact that this association varies by histologic cell 
type.  An increased duration of smoking cessation has been linked to a decreased 
risk of small cell and squamous cell carcinoma but not with adenocarcinoma (23,24). 
Apart from the role of histologic cell type in this association, the time that needs to 
pass before the risk of lung cancer among quitters reaches that of never smokers is 
less clear. Bosse et al (24) investigated the effect of smoking cessation on the 
molecular signature of smoking in lung tissues and showed that smokers who 
quitted more recently have the same gene-expression profile as current smokers, 
while over time this profile appears to change into the profile of never smokers. 
However, the mechanism underlying this association is still unclear and warrants 
further studies. 
One objective of our study was to investigate the potential effect modification of sex 
on the association between smoking and cause-specific mortality. Our results 
confirm the hypothesis by Henschke et al (25) that females may be more susceptible 
to develop lung cancer than males. A systematic review and meta-analysis of the 
epidemiological evidence on the association between lung cancer and smoking 
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showed that the relative risks for current smoking is higher in males compared to 
females and concluded that the observed higher relative risk for males does not 
necessarily reflect a higher susceptibility (26). The authors suggested that an 
increased exposure to occupational carcinogens and a different smoking history (e.g, 
longer smoking duration) can particularly explain the observed higher risk among 
males (26). 
Additionally, we observed that the effect of moderate and heavy smoking compared 
to ex-smoking on risk of all-cause mortality was more pronounced in females than in 
males. This may suggest that quitting smoking is more beneficial for females than 
males in term of lung cancer as well as all-cause mortality. More studies are needed 
to investigate whether to the same extent of exposure (number of smoked cigarette, 
duration, and depth of inhalation) the risks of cause-specific mortality vary by sex. 
Breast cancer mortality was not associated with baseline and lifetime smoking 
habits, duration of smoking or duration of smoking cessation. Whether there is an 
association between smoking and breast cancer remains debated. While the majority 
of studies reported no association, some studies suggested that this association is 
limited to pre-menopausal breast cancer and estrogen receptor positive breast cancer 
(27-31). Several mechanisms have been proposed for possible protective or 
carcinogenic effects of cigarette smoking on breast cancer incidence (27-31). A high 
level of estrogen is associated with an increased risk of breast carcinogenesis (30) 
and smoking has an anti-estrogenic capacity. Therefore, one of the proposed 
mechanisms is that cigarette smoking decreases the risk of breast cancer through this 
“anti-estrogenic” mechanism.  Smoking may enhance the metabolism of estradiol, 
increase the binding of estrogens by serum sex hormone-binding globulin, and lower 
the levels of estrogen derived from adipose tissue (31) thus leading to a decreased 
risk of breast cancer. However, as mentioned earlier, smoking has also been linked to 
an increased risk of breast cancer (30). Furthermore, the European Prospective 
Investigation into Cancer (EPIC) study on the association between smoking and 
breast cancer suggested that passive smoke exposure also plays a role in this. They 
reported that the risk estimates of active smoking for breast cancer were higher 
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when the reference group consisted of never smokers who were also not exposed to 
passive smoke, compared to when passive smoking was not taken into account (32).  
Apart from the above mentioned factors that can affect the association between 
smoking and cancer, it has been hypothesized that genetic variants in enzymes 
involved in the metabolism of carcinogens may also play a role in this association. 
Cigarette smoke contains many carcinogens such as polycyclic aromatic 
hydrocarbons, nitrosamines, and heterocyclic amines. In particular, the fact that 
susceptibility to these carcinogens may differ widely among individuals due to 
genetic variation may explain the observed discrepancy of results among studies. 
This suggests that the findings from one population for the association between 
smoking and cancer may not be easily generalizable to another population (33). 
Our findings regarding mortality due to CVD are in line with several other studies 
that reported that smoking is associated with increased risk of mortality due to CVD 
(1,3). Interestingly, subjects who quitted smoking during follow-up had no increased 
risk of mortality due to CVD compared to never smokers. In line with our finding, 
the majority of previous studies show that after smoking cessation, the risk of CVD 
mortality declines (32). This can be explained by the fact that the inflammatory 
component of CVD resulting from smoking is reversible after smoking cessation 
(34). However, the time period that needs to pass before the risk of CVD mortality 
among ex-smokers reaches that of never smokers is less clear. In addition, the level 
to which the inflammatory response declines after smoking cessation has not been 
subject of many studies. Therefore more studies are needed on the impact of 
smoking cessation regarding the risk of CVD mortality as well as other causes of 
death. 
Our analyses including pipe/cigar smokers among males revealed that heavy 
cigarette smoking at baseline was associated with an increased risk of all-cause 
mortality, and mortality due to CVD, any cancer, and lung cancer compared to 
pipe/cigar smokers. Contrary to the baseline findings, lifetime persistent cigarette 
smoking was not significantly associated with a higher risk of all-cause or cause-
specific mortality compared to pipe/cigar smoking.  
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Higher concentrations of nitrosamines, which are associated with an increased risk 
of  cancer, are found in pipe/cigar smoke than in cigarette smoke (14-16) and studies 
(11, 14, 35) suggest that switching to pipe/cigar smoking is not a safe alternative for 
cigarette smokers to reduce the risk of cancer. Shaper et al (35) investigated the 
impact of pipe/cigar smoking on all-cause mortality, cancer, and CVD and reported 
that both pipe/cigar smoking and mixed product smoking was associated with an 
increased risk of all-cause mortality, cancer incidence, and CVD compared to never 
smoking. Unfortunately, Shaper et al. did not address lifetime impact of (changes in) 
pipe/cigar smoking. 
One objective of our study was to use competing risk survival analysis to evaluate 
the impact of baseline and lifetime smoking on causes-specific mortality 
simultaneously. One of our interesting findings was that heavy smokers had  
a significantly higher risk to die of cancer than to die of CVD among all subjects, 
although this pattern was not significant among males or females separately.  
The major strength of our current study is the longitudinal design. We were able to 
follow our participants for 43 years, which provided a unique wide time window for 
evaluating the impact of lifetime (changes in) smoking habits on cause-specific 
mortality. Other strengths of our study are the large number of subjects included, 
and the high follow-up rate, since 98.5 % of the included subjects could be traced 
back (36). We studied the association between smoking and all-cause mortality and 
cancer mortality in four common types of cancer (lung cancer, colorectal cancer, 
prostate cancer and breast cancer), and CVD, while previous studies investigated 
overall mortality or any cancer mortality or only one specific cause of death.   
The lack of information on alcohol consumption, and menopause status of females 
may be considered a limitation in our study. Evidence shows that the menopause 
status of females and alcohol consumption may modify the effect of smoking on risk 
of cause-specific mortality (10). Another drawback of our study is that subjects were 
not asked about passive exposure to tobacco smoke. Therefore it is possible that 
some passive smokers were incorrectly classified as unexposed (never smokers).  
In summary, our findings, by addressing the impact of lifetime smoking habits in 
both sexes, corroborate and expand the ideas of Kenfield et al (10), who, in a study of 
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females, found stronger associations between smoking and mortality when using 
updated smoking status during follow-up compared to baseline measurements, 
suggesting that many of the previous studies may have underestimated the risk of 
mortality due to smoking by considering only single measurements (i.e. at baseline).  
In addition, our study suggests that the impact of lifetime cigarette and pipe/cigar 
smoking and duration of smoking vary for different causes of death and that 
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Table 1 Characteristics at baseline in the general population of Vlagtwedde-Vlaardingen, stratified by vital status after 40 years of follow-up (n=8465).  
 









C vs A d 
 
P-value 
C vs CVD d 
P-value 
C vs O 
P-value 
C vs E d 
            
All-causes (excluding 
external causes) 









than cancer or 
CVD (n=746) (O) 
External 
causes 
(n=150) (E) c 
     
            
All subjects, (%) a 53.2 43.4 22.2 14.1 8.8 1.8 1.4     
Men, n (%) 2121 (47.1) 2053 (55.9) 1071 (56.9) 696 (58.3) 370 (49.6) 98 (65.3) 70 (57.4) 0.00 0.22 0.00 0.06 
Age at first survey 
in years, mean (sd) 
30.2 (10.2) 48.8 (10.3) 50.2 (9.6) 45.9 (11.1) 49.8 (9.7) 43.0 (13.8) 33.2 (13.3) 0.00 0.00 0.00 0.01 
BMI at first survey,  
kg/m2  
    
24.4 (3.6) 26.7 (4.0) 27.0 (4.1) 26.3 (4.0) 26.6 (4.0) 24.9 (3.7) 24.0 (3.4) 0.00 0.00 0.19 0.00 
Vlagtwedde, n (%) 3004 (66.7) 2485 (67.7) 1274 (67.7) 762 (63.8) 522 (70.0) 110 (73.3) 54 (44.3) 0.06 0.31 0.01 0.02 
Smoking habits at  
baseline, n (%) 
           
Never smokers 1707 (38.9) 1364 (40.9) 684 (40.3) 392 (35.6) 340 (50.6) 50 (37.6) 47 (40.5)     
Ex-smokers 492 (11.2) 294 (8.8) 159 (9.4) 100 (9.1) 49 (7.3) 19 (14.3) 19 (16.4)     
Current smokers b        0.00 0.00 0.00 0.53 
      light  908 (20.7) 419 (12.6) 220 (13.0) 133 (12.1) 85 (12.6) 17 (12.8) 14 (12.1)     
      moderate  772 (17.6) 715 (21.5) 389 (22.9) 242 (22.0) 113 (16.8) 28 (21.1) 19 (14.6)     
      heavy 504 (11.5) 540 (16.2) 246 (14.5) 234 (21.3) 85 (12.6) 19 (14.3) 17 (14.7)     
Pack years in  
ever smoker,  
median (range) 
3.6 (0.5-117.2) 17.4 (0.1-262.2) 18.0 (0.1-111.7) 16.2 (0.1 -102.9) 16.9 (0.1-262.2) 14.8 (0.1-104.9) 0.5 (0.3-62.0) 0.00 0.07 0.77 0.06 
            
 
a All subjects: n=8465, and in 13 subjects the cause of death could not be determined.  
b Current smokers: light cigarette smokers < 10 cig/day, moderate cigarette smokers 10-20 cig/day, and heavy cigarette smokers > 20 cig/day. 
c Died due to external causes such as an accident, suicide or homicide. 




Table 2 Hazard ratio (with 95% confidence interval) of smoking habits at baseline for mortality from all-causes, CVD, any and specific types of cancer, 
among all 7074 subjects, in Cox regression with adjustment for age, sex, BMI and place of residence. (Reference category: never smokers. In interaction 
analyses by sex, for lung cancer in males and females the reference category is ex-smokers+ never smokers). 
 
 a Current smokers: light cigarette smokers < 10 cig/day, moderate cigarette smokers 10-20 cig/day, and heavy cigarette smokers > 20 cig/day. b  Females who died due to lung cancer reported 
no history of being ex-smokers at baseline. c  Males who died due to lung cancer reported no history of being never smokers at baseline.  
Smoking habits at baseline All-causes 




HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 




HR ( 95% CI) 
(females only) 
 
        
All subjects          





1.17 (1.00-1.37) 1.23 (0.98-1.54) 1.35 (1.04-1.75) 4.59 (2.03-10.37) 1.58 (0.77-3.27) 0.96 (0.37-2.50) 0.55 (0.17-1.77) 
Current smokers a        
light 1.31 (1.15-1.50) 1.42 (1.18-1.72) 1.29 (1.03-1.61) 7.06 (3.50-14.23) 1.60 (0.86-2.96) 0.78 (0.27-2.23) 0.90 (0.50-1.62) 
moderate 1.73 (1.52-1.97) 1.90 (1.58-2.30) 1.88 (1.51-2.33) 13.06 (6.60-25.74) 1.40 (0.71-2.77) 0.70 (0.29-1.73) 1.48 (0.74-2.96) 
heavy 2.04 (1.77-2.36) 1.96 (1.58-2.41) 2.73 (2.17-3.43) 26.55 (13.40-52.63) 1.62 (0.75-3.50) 1.05 (0.42-2.66) 1.47 (0.46-4.74) 
Sex-stratified analysis        
Effect in females b        
Never smokers 1 1 1 1 1   
Ex-smokers 1.00 (0.74-1.34) 1.16 (0.77-1.73) 0.86 (0.51-1.45)  1.09 (0.26-4.57)   
Current smokers        
light 1.20 (1.01-1.43) 1.33 (1.04-1.71) 1.26 (0.95-1.66) 7.89 (3.69-16.85) 0.95 (0.37-2.44)   
moderate 2.07 (1.67-2.55) 1.93 (1.39-2.68) 2.25 (1.63-3.10) 9.68 (3.91-23.98) 4.26 (1.92-9.45)   
heavy 1.91 (1.34-2.72) 2.05 (1.24-3.38) 2.31 (1.37-3.91) 25.99 (10.15-66.55)   3.02 (0.72-12.71)   
Effect in males c        
Never smokers 1 1 1  1   
Ex-smokers 1.30 (1.02-1.65) 1.35 (0.95-1.90) 1.68 (1.11-2.54) 1 1.36 (0.47-3.92)   
Current smokers        
light 1.50 (1.18-1.91) 1.61 (1.14-2.28) 1.45 (0.94-2.23) 1.65 (0.76-3.57) 1.85 (0.65-5.24)   
moderate 1.78 (1.44-2.21) 2.05 (1.51-2.79) 1.99 (1.36-2.90) 3.88 (2.18-6.92) 0.74 (0.26-2.13)   
heavy 2.18 (1.75-2.72) 2.10 (1.53-2.90) 3.06 (2.10-4.46) 7.64 (4.33-13.64) 1.17 (0.41-3.36)   
Interaction between smoking habits and sex        
Ex-smoking 1.30 (0.89-1.91) 1.17 (0.68-1.99) 
97) 
1.95 (1.00-3.80) 1 1.24 (0.21-7.39)   
Current smokers        
light 1.25 (0.93-1.68) 1.21 (0.79-1.85) 1.15 (0.69-1.93) 0.21 (0.07-0.62) 1.95 (0.48-8.02)   
moderate 0.86 (0.64-1.17) 1.06 (0.68-1.66) 0.89 (0.54-1.46) 0.40 (0.14-1.18) 0.17 (0.05-0.66)   
heavy 1.15 (0.75-1.74) 1.03 (0.57-1.86) 1.32 (0.69-2.53) 0.29 (0.10-0.88) 0.39 (0.07-2.30)   
Pack years in ever smoker 1.01 (1.01-1.01) 1.01 (1.00-1.01) 1.01 (1.00-1.02) 1.02 (1.01-1.02) 1.01 (0.99-1.02) 1.01 (1.00-1.03) 0.98 (0.92-1.04) 
Sex-stratified analysis         
Effect in females  1.02 (1.01-1.03) 1.02 (1.00-1.03) 1.03 (1.01-1.05) 1.05 (1.02-1.09) 1.08 (1.04-1.11)   
Effect in males b 1.01 (1.01-1.01) 1.01 (1.00-1.01) 1.01 (1.00-1.02) 1.02 (1.01-1.02) 1.00 (0.98-1.02)   
Interaction between pack years and sex 0.99 (0.98-1.00) 0.99 (0.97-1.01) 0.98 (0.96-1.00) 0.96 (0.94-0.99) 0.93 (0.90-0.96)   




Table 3 Hazard ratio (with 95% confidence interval) of lifetime smoking habits for mortality from all causes, CVD, any cancer, lung cancer, 
colorectal cancer among all 3925 subjects, prostate cancer among 2067 males and breast cancer among 1858 females in Cox regression with 



















a lifetime smoking habits were defined within the interval between the baseline survey and the last available survey as follows: 1) Never smokers: subjects who reported no smoking 
history at baseline and remained non-smokers during the interval, 2) Ex-smokers: subjects who were ex-smokers at baseline and remained  ex-smokers during the interval, 3) Quitters: 
subjects who were current smokers (cigarette or pipe/cigar) at baseline but successfully quitted smoking during the interval, 4) Persistent smokers: subjects who were current smokers 
(cigarette or pipe/cigar) at baseline and remained smokers during the interval, and 5) unstructured smokers which consists of the remaining subjects. b Females who died due to lung 
cancer were not persistent ex-smokers, or unstructured smokers during follow-up. c Males who died due to cancer were not persistent never smokers during follow-up. NA: The model 
did not converge. 
  
Lifetime smoking habits a All-causes 




HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 




HR ( 95% CI) 
(females only) 
 
        
All subjects        
Never smoker 1 1 1 1 1 1 1 
Persistent ex-smoker 1.02 (0.79-1.33) 1.23 (0.85-1.79) 0.98 (0.64-1.49) 1.80 (0.46-6.96) 0.76 (0.22-2.66) 1.04 (0.20-5.37) 1.09 (0.25-4.70) 
Quitters 0.99 (0.81-1.21) 1.06 (0.79-1.43) 1.18 (0.87-1.61) 3.65 (1.32-10.10) 0.89 (0.35-2.27) 0.55 (0.11-2.64) 1.49 (0.65-3.42) 
Persistent cigarette smokers 1.92 (1.61-2.30) 2.11 (1.61-2.76) 2.06 (1.56-2.72) 11.45 (4.39-29.87) 1.22 (0.50-2.99) 0.79 (0.17-3.60) 0.73 (0.28-1.88) 
Unstructured  0.92 (0.69-1.23) 1.05 (0.69-1.59) 1.05 (0.68-1.62) 1.98 (0.47-8.40) 0.59 (0.13-2.66) 0.91 (0.13-6.55) 0.76 (0.22-2.57) 
        
Sex-stratified analysis        
Effect in females b        
Never smoker 1 1 1 NA 1   
Persistent ex-smoker 1.16 (0.74-1.84) 1.60 (0.88-2.93) 
 
0 
0.72 (0.29-1.76) NA 1.20 (0.16-9.27)   
Quitters 0.86 (0.62-1.18) 0.93 (0.58-1.48) 1.06 (0.67-1.69) NA 0.76 (0.17-3.43)   
Persistent cigarette smokers 1.85 (1.47-2.34) 2.08 (1.48-2.93) 
 
1.77 (1.23-2.55) NA 1.51 (0.47-4.83)   
Unstructured  0.83 (0.57-1.23) 0.86 (0.48-1.54) 1.04 (0.60-1.80) NA 0.57 (0.07-4.41)   
Effect in males c        
Never smoker 1 1 1 NA 1   
Persistent ex-smoker 1.18 (0.76-1.83) 1.32 (0.68-2.56) 1.63 (0.76-3.49) NA 0.52 (0.08-3.31)   
Quitters 1.24 (0.83-1.83) 1.27 (0.69-2.33) 1.89 (0.94-3.78) NA 0.72 (0.15-3.42)   
Persistent cigarette smokers 2.31 (1.58-3.38) 2.44 (1.36-4.39) 3.32 (1.69-6.49) NA 0.91 (0.20-4.12)   
Unstructured  1.20 (0.72-1.99) 1.44 (0.68-3.05) 1.54 (0.65-3.65) NA 0.50 (0.05-5.51)   
Interaction between lifetime 
smoking habits and sex 
  
Never smoker 1 1 1 NA 1   
Persistent ex-smoker 1.02 (0.54-1.92) 0.82 (0.34-2.02) 2.28 (0.70-7.45) NA 0.43 (0.03-6.98)   
Quitters 1.44 (0.87-2.40) 1.37 (0.64-2.94) 1.78 (0.77-4.10) NA 0.95 (0.11-8.28)   
Persistent cigarette smokers 1.25 (0.80-1.95) 1.18 (0.59-2.33) 1.87 (0.87-4.05) NA 0.60 (0.09-4.12)   
Unstructured  1.44 (0.76-2.72) 1.68 (0.65-4.33) 1.48 (0.53-4.13) NA 0.87 (0.04-20.45)   




Table 4 Hazard ratio (with 95% confidence interval) of smoking habits including pipe/cigar smoking for mortality from CVD, any 
cancer, lung cancer, colorectal cancer, prostate cancer, among 3480 males in the analyses on baseline and among 2067 males in the 















              











HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 
HR ( 95% CI) 
 
Baseline  smoking habits         
Never smokers 0.71 (0.55-0.91) 0.68 (0.48-0.97) 0.63 (0.40-0.97) - 0.90 (0.28-2.90) 1.32 (0.46-3.81) 
Ex-smokers 0.92 (0.75-1.13) 0.91 (0.69-1.22) 1.04 (0.73-1.48) 0.82 (0.39-1.73) 1.37 (0.52-3.60) 1.39 (0.54-3.60) 
Current smokers       
light 1.07 (0.87-1.31) 1.10 (0.83-1.47) 0.89 (0.61-1.29) 0.80 (0.37-1.74) 1.61 (0.62-4.15) 1.02 (0.35-2.95) 
moderate 1.25 (1.05-1.49) 1.39 (1.10-1.77) 1.21 (0.89-1.64) 1.85 (1.03-3.32) 0.65 (0.25-1.70) 0.93 (0.38-2.32) 
heavy 1.53 (1.28-1.83) 1.40 (1.08-1.80) 1.91 (1.41-2.60) 3.77 (2.12-6.70) 1.01 (0.39-2.65) 1.40 (0.54-3.55) 
Pipe/cigar smokers 1 1 1 1 1 1 
       
Lifetime smoking habits       
Never smoker 0.56 (0.29-1.07) 0.63 (0.22-1.78) 0.27 (0.11-0.71) - 0.48 (0.04-5.45) 0.65 (0.06-7.34) 
Persistent ex-smoker 0.66 (0.36-1.19) 0.84 (0.33-2.17) 0.43 (0.20-0.95) 0.12 (0.03-0.55) 0.42 (0.04-4.16) 0.67 (0.08-5.80) 
Quitters 0.68 (0.39-1.20) 0.81 (0.33-2.00) 0.49 (0.24-1.02) 0.35 (0.10-1.18) 0.46 (0.06-3.69) 0.36 (0.04-2.88) 
Persistent  cigarette smokers 1.32 (0.76-2.30) 1.61 (0.66-3.93) 0.85 (0.42-1.74) 1.04 (0.32-3.33) 0.36 (0.04-2.92) 0.47 (0.06-3.80) 
Persistent pipe/cigar smokers 1 1 1 1 1 1 
Persistent mixed smokers* 1.17 (0.63-2.15) 1.34 (0.51-3.54) 1.04 (0.47-2.29) 0.71 (0.18-2.77) 0.90 (0.09-8.74) 0.59 (0.05-6.56) 
Unstructured  0.66 (0.35-1.27) 0.91 (0.33-2.48) 0.41 (0.17-1.02) 0.31 (0.06-1.55) 0.28 (0.02-4.60) 0.59 (0.05-6.61) 




Table 5 Hazard ratio (with 95% confidence interval) of duration of smoking for mortality from any cancer, lung cancer, colorectal cancer in Cox 










HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 
HR ( 95% CI) 
 
Breast cancer 
HR ( 95% CI) 
         
        
All subjects        
Duration of smoking 1.01 (0.99-1.03) 1.00 (0.98-1.02) 1.03 (1.00-1.06) 1.10 (1.03-1.17) 0.98 (0.91-1.05) 0.98 (0.89-1.09) 0.99 (0.90-1.09) 
Duration of smoking cessation 0.98 (0.96-0.99) 0.97 (0.95-1.00) 0.99 (0.96-1.03) 1.02 (0.95-1.10) 0.96 (0.88-1.04) 0.98 (0.88-1.10) 1.03 (0.92-1.14) 
Sex-stratified analysis        
Effect in Females        
Duration of smoking 1.01 (0.99-1.03) 1.00 (0.98-1.03) 1.02 (0.99-1.06) 1.07 (0.99-1.16) 1.04 (0.95-1.14)   
Duration of smoking cessation 0.97 (0.94-1.00) 0.98 (0.94-1.01) 0.98 (0.94-1.03) 0.84 (0.66-1.08) 1.02 (0.91-1.14)   
Effect in Males        
Duration of smoking 1.01 (0.99-1.03) 1.00 (0.98-1.03) 1.03 (1.00-1.06) 1.10 (1.03-1.17) 0.94 (0.87-1.02)   
Duration of smoking cessation 0.98 (0.96-1.00) 0.97 (0.94-1.00) 1.00 (0.96-1.03) 1.03 (0.96-1.11) 0.92 (0.84-1.01)   
Interaction         
Duration of smoking 1.00 (0.99-1.02) 1.00 (0.98-1.02) 1.01 (0.99-1.04) 1.03 (0.98-1.08) 0.91 (0.83-0.99)   
Duration of smoking cessation 1.01 (0.98-1.03) 0.99 (0.96-1.03) 1.01 (0.97-1.06) 1.22 (0.96-1.56) 0.91 (0.81-1.02)   


























 a Cancer of trachea, bronchus and lung. 
 b Cancer of colon and rectum (further referred to as colorectal cancer). 
 
ICD-version ICD-7 ICD-8 ICD-9 ICD-10 
     
Years of use 1965-1968 1969-1978 1979-1995 1996-2008 
External causes of death ≥800 ≥800 ≥800 S, T, V, W, X, Y 
Death due to cardiovascular 
disease  
330-334, 400-416, 420-422, 
430-434, 440-447, 450-456, 
460-468, 782.4 
390-398, 400-404, 410-414, 
420-429, 430-438, 440-448 
(excl.444.2), 450-458, 782.4 
390-398, 401-405, 410-417, 
420-438, 440-448, 451-459, 
785.4 
G45-G46, I00-I15, I20-I28, 
I30-I52, I60-I69,  
I70-I79, I80-I89, I95-I97, 
I98.2, I98.8, I99, M30-M31, 
N28.0, R02, R58 
Death due to cancer     
Any cancer 140-239 , 294 140-239 140-239 , 288 C00-C97, D00-D48 
Lung cancer a 162, 163 162, 163 162, 163, 165 C33, C34, C38, C39 
Colorectal cancer b 153, 154 153, 154 153, 154 C18-C21 
Prostate cancer 177 185 185 C61 




Supplementary table 2 Number of subjects (%) who died due to all-cause and cause-specific mortality, in a general population of Vlagtwedde-Vlaardingen 
during 40 years of follow-up according to different smoking habits at baseline.  
 
 
 Current smokers: light cigarette smokers < 15 cig/day, moderate cigarette smokers 15-25 cig/day, and heavy cigarette smokers > 15 cig/day. 














 events/censored events/censored events/censored events/censored events/censored events/censored events/censored 
 n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) 
All subjects        





246 (32.8)/504 (67.2) 127 (16.9)/623 (83.1) 92 (12.3)/658 (87.7) 14 (1.9)/736 (98.1) 13 (1.7)/737 (98.3)   
Current smokers  a        
      Light  352 (27.7)/917 (72.3) 175 (13.8)/1094 (86.2) 121 (9.5)/1148 (90.5) 28 (2.2)/1241 (97.8) 17 (1.3)/1252 (98.7)   
      Moderate  626 (44.4)/784 (55.6) 332 (23.5)/1078 (76.5) 222 (15.7)/1188 (84.3) 74 (5.2)/1336 (94.8) 19 (1.3)/1391 (98.7)   
      Heavy 447 (46.4)/516 (53.6) 204 (21.1)/759 (78.8) 200 (20.8)/763 (79.2) 93 (9.7)/870 (90.3) 13 (1.3)/950 (98.7)   
        
Females        
Never smokers 895 (42.3)/1220 (57.7) 451 (21.3)/1664 (78.7) 275 (13.0)/1840 (87.0) 12 (0.6)/2103 (99.4) 38 (1.8)/2077 (98.2)  73 (3.5)/2042 (96.5) 
Ex-smokers 47 (18.3)/210 (81.7) 25 (9.7)/232 (90.3) 15 (5.8)/242 (94.2) 0 (0.0)/257 (100.0) 2 (0.8)/255 (99.2)  3 (1.2)/254 (98.8) 
Current smokers        
      Light  160 (21.2)/596 (78.8) 78 (10.3)/678 (89.7) 64 (8.5)/692 (91.5) 16 (2.1)/740 (97.9) 5 (0.7)/751 (99.3)  15 (2.0)/741 (98.0) 
      Moderate  101 (28.0)/260 (72.0) 41 (11.4)/320 (88.6) 45 (12.5)/316 (87.5) 8 (2.2)/353 (97.8) 8 (2.2)/353 (97.8)  10 (2.8)/351 (97.2) 
      Heavy 32 (30.5)/73 (69.5) 16 (15.2)/89 (84.8) 15 (14.3)/90 (85.7) 7 (6.7)/98 (93.3) 2 (1.9)/103 (98.1)  3 (2.9)/102 (97.1) 
            
Males        
Never smokers 99 (17.5)/468 (82.5) 47 (8.3)/520 (91.7) 32 (5.6)/535 (94.4) 0 (0.0)/567 (100.0) 5 (0.9)/562 (99.1) 7 (1.2)/560 (98.8)  
Ex-smokers 199 (40.4)/294 (59.6) 102 (20.7)/391 (79.3) 77 (15.6)/416 (84.4) 14 (2.8)/479 (97.2) 11 (2.2)/482 (97.8) 12 (2.4)/481 (97.6)  
Current  smokers        
      Light  192 (37.4)/321 (62.6) 97 (18.9)/416 (81.1) 57 (11.1)/456 (88.9) 12 (2.3)/501 (97.7) 12 (2.3)/501 (97.7) 7 (1.4)/506 (98.6)  
      Moderate  525 (50.0)/524 (50.0) 291 (27.7)/758 (72.3) 177 (16.9)/872 (83.1) 66 (6.3)/983 (93.7) 11 (1.0)/1038 (99.0) 15 (1.4)/1034 (98.6)  
      Heavy 415 (48.4)/443 (51.6) 188 (21.8)/670 (78.1) 185 (21.6)/673 (78.4) 86 (10.0)/772 (90.0) 11 (1.3)/847 (98.7) 13 (1.5)/845 (98.5)  
Pipe/cigar smokers 174 (60.8)/112 (39.2) 92 (32.2)/194 (67.8) 55 (19.2)/231 (80.8) 14 (4.9)/272 (95.1) 7 (2.4)/279 (97.6) 7 (11.5)/279 (97.6)  
        
Pack years in ever smokers       
All subjects  1612 (37.3)/2713 (62.7) 800 (18.5)/3525 (81.5) 620 (14.3)/3705 (85.7) 201 (4.6)/4124 (95.4) 62 (1.4)/4263 (98.6)   
Females  
 
302 (22.1)/1067 (77.9) 135 (9.9)/1234 (90.1) 129 (9.4)/1240 (90.6) 28 (2.0)/1341 (98.0) 15 (1.1)/1354 (98.9)  30 (2.2)/1339 (97.8) 
Males  1310 (44.3)/1646 (55.7) 665 (22.5)/2291 (77.5) 491 (16.6)/2465 (83.4) 173 (5.9)/2783 (94.1) 47 (1.6)/2909 (98.4) 43 (1.5)/2913 (98.5)  




Supplementary table 3 Number of subjects (%) who died due to all-cause and cause-specific mortality, in a general population of Vlagtwedde-Vlaardingen 




a lifetime smoking habits were defined within the interval between the baseline survey and the last available survey as follows: 1) Never smokers: subjects who reported no smoking history at 
baseline and remained non-smokers during the interval, 2) Ex-smokers: subjects who were ex-smokers at baseline and remained  ex-smokers during the interval, 3) Quitters: subjects who were 
current smokers (cigarette or pipe/cigar) at baseline but successfully quitted smoking during the interval, 4) Persistent smokers: subjects who were current smokers (cigarette or pipe/cigar) at 
baseline and remained smokers during the interval, and 5) unstructured smokers which consists of the remaining subjects 
  
Lifetime smoking habit  a All-causes 
 










 events/censored events/censored events/censored events/censored events/censored events/censored events/censored 
 n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) 
All subjects        
Never smoker 252(24.5)/776(75.5) 112(10.9)/916 (89.1) 97 (9.4)/931 (90.6) 5 (0.5)/1023 (99.5) 14 (1.4)/1014 (98.6)   
Persistent ex-smoker 90 (30.8)/202 (69.2) 47 (16.1)/245 (83.9) 33 (11.3)/259 (88.7) 4 (1.4)/288 (98.6) 4 (1.4)/288 (98.6)   
Quitters 233 (27.5)/613 (72.5) 108(12.8)/738 (87.2) 104 (12.3)/742 (87.7) 22 (2.6)/824 (97.4) 11 (1.3)/835 (98.7)   
Persistent smokers  507 (36.0)/901 (64.0) 232(16.5)/1176 (83.5) 214(15.2)/1194 (84.8) 83 (5.9)/1325 (94.1) 15 (1.1)/1393 (98.9)   
Unstructured  60 (17.1)/291 (82.9) 29 (8.3)/322 (91.7) 27 (7.7)/324 (92.3) 3 (0.9)/348 (99.1) 2 (0.6)/349 (99.4)   
        
Females        
Never smoker 223 (27.5)/588 (72.5) 100 (12.3)/711 (87.7) 88 (10.9)/723 (89.1) 5 (0.6)/806 (99.4) 12 (1.5)/799 (98.5)  21 (2.6)/790 (97.4) 
Persistent ex-smoker 20  (21.1)/75 (78.9) 12 (12.6)/83 (87.4) 5 (5.3)/90 (94.7) 0 (0.0)/95 (100.0) 1 (1.1)/94 (98.9)  2 (2.1)/93 (97.9) 
Quitters  46 (16.1)/240 (83.9) 22 (7.7)/264 (92.3) 23 (8.0)/263 (92.0) 1 (0.3)/285 (99.7) 2 (0.7)/284 (99.3)  8 (2.8)/278 (97.2) 
Persistent cigarette smokers 114 (23.9)/363 (76.1) 53 (11.1)/424 (88.9) 47 (9.9)/430 (90.1) 17 (3.6)/460 (96.4) 4 (0.8)/473 (99.2)  6 (1.3)/471 (98.7) 
Unstructured  29 (15.3)/160 (84.7) 13 (6.9)/176 (93.1) 15 (7.9)/174 (92.1) 0 (0.0)/189 (100.0) 1 (0.5)/188 (99.5)  3 (1.6)/186 (98.4) 
        
Males        
Never smoker 29 (13.4)/188 (86.6) 12 (5.5)/205 (94.5) 9 (4.1)/208 (95.9) 0 (0.0)/217 (100.0) 2 (0.9)/215 (99.1) 2 (0.9)/215 (99.1)  
Persistent ex-smoker 70 (35.5)/127 (64.5) 35 (17.8)/162 (82.2) 28 (14.2)/169 (85.8) 4 (2.0)/193 (98.0) 3 (1.5)194 (98.5) 6 (3.0)/191 (97.0)  
Quitters  187 (33.4)/373 (66.6) 86 (15.4)/474 (84.6) 81 (14.5)/479 (85.5) 21 (3.8)/539 (96.3) 9 (1.6)/551 (98.4) 8 (1.4)/552 (98.6)  
Persistent  cigarette  smokers 330 (41.8)/460 (58.2) 152 (19.2)/638 (80.8) 132 (16.7)/658 (83.3) 56 (7.1)/734 (92.9) 7 (0.9)/783 (99.1) 8 (1.0)/782 (99.0)  
Persistent pipe/cigar smokers 13 (38.2)/21 (61.8) 5 (14.7)/29 (85.3) 8 (23.5)/26 (76.5) 3 (8.8)/31 (91.2) 1 (2.9)/33 (97.1) 1 (2.9)/33 (97.1)  
Persistent mixed smokers 50 (46.7)/57 (53.3) 22 (20.6)/85 (79.4) 27 (25.2)/80 (74.8) 7 (6.5)/100 (93.5) 3 (2.8)/104 (97.2) 2 (1.9)/105 (98.1)  
Unstructured  31 (19.1)/131 (80.9) 16 (9.9)/146 (90.1) 12 (7.4)/150 (92.6) 3 (1.9)/159 (98.1) 1 (0.6)/161 (99.4) 2 (1.2)/160 (98.8)  




Supplementary table 4 Number of subjects (%) who died due to all-cause and cause-specific mortality and number of censored subjects (%) included in the 











HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 
HR ( 95% CI) 
 
Breast cancer 
HR ( 95% CI) 
         
Duration of smoking 
and cessation 
events/censored events/censored events/censored events/censored events/censored events/censored events/censored 
n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) n (%)/n (%) 
All subjects 822 (32.9)/1676 (67.1) 384 (15.4)/2114 (84.6) 347 (13.9)/2151 (86.1) 109 (4.4)/2389 (95.6) 29 (1.2)/2469 (98.8)   
Females 175 (21.3)/645 (78.7) 85 (10.4)/735 (89.6) 73 (8.9)/747 (91.1) 18 (2.2)/802 (97.8) 7 (0.9)/813 (99.1)  15 (1.8)/805 (98.2) 




Supplementary table 5 Hazard ratio (with 95% confidence interval) of smoking habits at baseline for mortality from all-causes, CVD, any and specific types of 
cancer, among all 7074 subjects, in Cox regression with adjustment for age, sex, BMI and place of residence (Reference  category: ex- smokers). 
 
NA: The model did not converge.
Smoking  habits  
at baseline 
All-causes 




HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 




HR ( 95% CI) 
(females only) 
 
All subjects        





1 1 1 1 1 1 1 
Current smokers a        
light 1.12 (0.95-1.33) 1.16 (0.92-1.46) 0.95 (0.72-1.26) 1.54 (0.80-2.95) 1.01 (0.48-2.12) 0.74 (0.29-1.89) 1.64 (0.47-5.66) 
moderate 1.48 (1.28-1.72) 1.55 (1.26-1.90) 1.39 (1.09-1.77) 2.84 (1.60-5.04) 0.89 (0.44-1.80) 0.67 (0.31-1.44) 2.69 (0.74-9.80) 
heavy 1.75 (1.49-2.04) 1.59 (1.27-1.99) 2.02 (1.57-2.59) 5.78 (3.28-10.19) 1.02 (0.47-2.22) 1.00 (0.45-2.22) 2.68 (0.54-13.32) 
        
Interaction of smoking habits with sex 
Effect in females b 
      
      
Never smokers 1.01 (0.75-1.35) 0.87 (0.58-1.30) 1.16 (0.69-1.96) NA 0.91 (0.22-3.82)   
Ex-smokers 1 1 1 NA 1   
Current smokers        
light 1.21 (0.87-1.67) 1.16 (0.74-1.81) 1.46 (0.83-2.56) NA 0.86 (0.17-4.46)   
moderate 2.08 (1.47-2.94) 1.67 (1.02-2.75) 2.61 (1.45-4.68) NA 3.90 (0.83-18.40)   
heavy 1.92 (1.22-3.01) 1.78 (0.95-3.33) 2.69 (1.31-5.50) NA 2.76 (0.39-19.66)   
        
Effect in males c        
Never smokers 0.77 (0.61-0.98) 0.74 (0.53-1.05) 0.60 (0.39-0.90) NA 0.74 (0.26-2.12)   
Ex-smokers 1 1 1 NA 1   
Current smokers        
light 1.16 (0.95-1.42) 1.20 (0.91-1.58) 0.86 (0.61-1.22) NA 1.36 (0.60-3.08)   
moderate 1.38 (1.17-1.62) 1.52 (1.21-1.91) 1.19 (0.91-1.55) NA 0.54 (024-1.26)   
heavy 1.69 (1.42-2.00) 1.56 (1.23-1.90) 1.83 (1.40-2.39) NA 0.86 (0.37-1.99)   
        
Interaction         
Never smoker 0.77 (0.52-1.13) 0.86 (0.50-1.46) 0.51 (0.26-1.00) NA 0.80 (0.14-4.78)   
Ex-smoking 1 1 1 NA 1   
Current smokers        
light 0.96 (0.66-1.41) 1.04 (0.61-1.76) 0.59 (0.31-1.14) NA 1.57 (0.25-9.83)   
moderate 0.66 (0.45-0.97) 0.91 (0.53-1.57) 0.46 (0.24-0.87) NA 0.14 (0.02-0.81)   
heavy 0.88 (0.54-1.42) 0.88 (0.45-1.73) 0.68 (0.32-1.46) NA 0.31 (0.04-2.63)   








Smoking habits at 
baseline 
Cancer mortality 
HR (95% CI) 
CVD mortality 
HR (95% CI) 
Other mortality 
HR (95% CI) 
Difference CVD 
mortality vs Cancer 
mortality 
HR (95% CI) 
Difference Other mortality 
vs Cancer mortality 
HR (95% CI) 
Difference Other 
mortality  vs CVD 
mortality 
HR (95% CI) 
       
All subjects       
Never smokers 1 1 1 1 1  
Ex-smokers 1.41 (1.11-1.80) 1.20 (0.98-1.48) 0.81 (0.58-1.14) 0.85 (0.63-1.15) 0.57 (0.38-0.86) 0.68 (0.46-1.00) 
Current smokers       
light 1.47 (1.18-1.83) 1.32 (1.10-1.58) 1.13 (0.86-1.47) 0.90 (0.69-1.18) 0.77 (0.55-1.07) 0.85 (0.62-1.16) 
Moderate 1.98 (1.63-2.40) 1.83 (1.55-2.15) 1.16 (0.91-1.50) 0.92 (0.74-1.15) 0.59 (0.44-0.79) 0.64 (0.49-0.84) 
Heavy 2.94 (2.41-3.59) 1.85 (1.54-2.23) 1.31 (0.98-1.75) 0.63 (0.50-0.80) 0.45 (0.32-0.62) 0.71 (0.51-0.97) 
       
Females       
Never smokers 1 1 1 1 1 1 
Ex-smokers 1.06 (0.63-1.79) 1.08 (0.72-1.62) 0.96 (0.51-1.81) 1.02 (0.53-1.97) 0.91 (0.40-2.06) 0.89 (0.42-1.88) 
Current smokers       
light 1.64 (1.24-2.17) 1.20 (0.94-1.53) 0.86 (0.58-1.28) 0.73 (0.51-1.05) 0.52 (0.32-0.85) 0.71 (0.45-1.14) 
Moderate 3.10 (2.25-4.28) 1.75 (1.26-2.42) 1.68 (1.03-2.74) 0.56 (0.36-0.88) 0.54 (0.31-0.97) 0.96 (0.54-1.72) 
Heavy 2.94 (1.75-4.97) 1.99 (1.20-3.29) 0.90 (0.29-2.80) 0.68 (0.33-1.39) 0.30 (0.09-1.07) 0.45 (0.13-1.56) 
       
Males       
Never smokers 1 1 1 1 1 1 
Ex-smokers 1.56 (1.04-2.37) 1.39 (0.98-1.97) 0.75 (0.44-1.27) 0.89 (0.52-1.52) 0.48 (0.25-0.94) 0.54 (0.29-1.01) 
Current smokers       
light 1.40 (0.91-2.16) 1.62 (1.14-2.30) 1.36 (0.84-2.20) 1.16 (0.67-2.02) 0.97 (0.51-1.86) 0.84 (0.46-1.52) 
Moderate 1.86 (1.28-2.72) 2.06 (1.51-2.81) 1.05 (0.67-1.63) 1.11 (0.68-1.80) 0.56 (0.32-1.01) 0.51 (0.30-0.87) 
Heavy 3.03 (2.08-4.41) 2.06 (1.49-2.83) 1.28 (0.81-2.02) 0.68 (0.41-1.11) 0.42 (0.23-0.76) 0.62 (0.36-1.09) 
       
Packyears       
All subjects 1.01 (1.00-1.01) 1.01 (1.01-1.01) 1.01 (1.00-1.02) 1.00 (1.00-1.01) 1.00 (1.00-1.01) 1.00 (0.99-1.01) 
Females 
 
1.03 (1.01-1.05) 1.03 (1.01-1.05) 1.00 (0.97-1.04) 1.00 (0.98-1.03) 0.98 (0.94-1.02) 0.98 (0.94-1.02) 
Males 1.01 (1.00-1.01) 1.01 (1.00-1.01) 1.01 (1.00-1.02) 1.00 (1.00-1.01) 1.01 (1.00-1.01) 1.00 (1.00-1.01) 





Supplementary table 7 Hazard ratio (with 95% confidence interval) of lifetime smoking habits for mortality from CVD, any cancer, lung cancer, colorectal 
cancer, among all 3925 subjects, prostate cancer among 2067 males and breast cancer among 1858 females in Cox regression with adjustment for age, sex, BMI 
and place of residence. (Reference category: persistent smokers). 
 
 
NA: The model did not converge.  
Lifetime smoking habits   All-causes 




HR ( 95% CI) 
 
Any cancer 
HR ( 95% CI) 
 
Lung cancer 
HR ( 95% CI) 
 
Colorectal cancer 
HR ( 95% CI) 
 
Prostate cancer 




HR ( 95% CI) 
(females only) 
 
        
All subjects        
Never smoker 0.52 (0.44-0.62) 0.47 (0.36-0.62) 0.49 (0.37-0.64) 0.09 (0.03-0.23) 0.82 (0.34-2.00) 1.27 (0.28-5.77) 1.38 (0.53-3.58) 
Persistent ex-smoker 0.53 (0.42-0.67) 0.59 (0.43-0.81) 0.47 (0.33-0.69) 0.16 (0.06-0.43) 0.62 (0.19-1.97) 1.31 (0.46-3.74) 1.50 (0.30-7.48) 
Quitters 0.52 (0.44-0.61) 0.50 (0.40-0.63) 0.57 (0.45-0.73) 0.32 (0.20-0.51) 0.73 (0.33-1.61) 0.69 (0.27-1.75) 2.05 (0.70-6.00) 
Persistent cigarette smokers 1 1 1 1 1 1 1 
Unstructured  0.48 (0.37-0.63) 0.50 (0.34-0.74) 0.51 (0.34-0.76) 0.17 (0.05-0.55) 0.48 (0.11-2.16) 1.15 (0.25-5.23) 1.04 (0.26-4.21) 
        
Interaction of lifetime smoking  
habits with sex Effect in females b Never smoker 0.54 (0.43-0.68) 0.48 (0.34-0.68) 0.57 (0.39-0.81) NA 0.66 (0.21-2.12)   
Persistent ex-smoker 0.63 (0.39-1.01) 0.77 (0.41-1.45) 0.40 (0.16-1.02) NA 0.79 (0.09-7.15)   
Quitters 0.46 (0.33-0.65) 0.45 (0.27-0.74) 0.60 (0.36-0.99) NA 0.51 (0.09-2.79)   
Persistent cigarette smokers 1 1 1 NA 1   
Unstructured  0.45 (0.30-0.68) 0.41 (0.23-0.76) 0.59 (0.33-1.05) NA 0.38 (0.04-3.42)   
        
Effect in males c        
Never smoker 0.43 (0.30-0.63) 0.41 (0.23-0.74) 0.30 (0.15-0.59) NA 1.10 (0.24-5.01)   
Persistent ex-smoker 0.51 (0.40-0.66) 0.54 (0.37-0.78) 0.49 (0.33-0.74) NA 0.57 (0.15-2.20)   
Quitters 0.53 (0.45-0.64) 0.52 (0.40-0.67) 0.57 (0.44-0.75) NA 0.80 (0.33-1.95)   
Persistent cigarette smokers 1 1 1 NA 1   
Unstructured  0.52 (0.36-0.75) 0.59 (0.35-0.98) 0.46 (0.26-0.83)  0.55 (0.07-4.25)   
        
Interaction  
smoking habits with sex 
  
Never smoker 0.80 (0.51-1.25) 0.85 (0.43-1.68) 0.53 (0.25-1.15) NA 
NA 
1.66 (0.24-11.40)   
Persistent ex-smoker 0.81 (0.47-1.40) 0.70 (0.34-1.45) 1.22 (0.45-3.33) NA 0.72 (0.06-9.34)   
Quitters 1.15 (0.79-1.69) 1.16 (0.66-2.03) 0.95 (0.54-1.67) NA 1.58 (0.23-10.69)   
Persistent cigarette smokers 1 1 1 NA 1   
Unstructured  1.15 (0.67-1.99) 1.42 (0.64-3.15) 0.79 (0.35-1.80) NA 1.44 (0.07-29.04)   













habits   
Cancer mortality 
HR (95% CI) 
CVD mortality 
HR (95% CI) 
Other mortality 
HR (95% CI) 
Difference CVD mortality 
vs Cancer mortality 
HR (95% CI) 
Difference Other mortality vs 
Cancer mortality 
HR (95% CI) 
 
Difference Other mortality  
vs CVD mortality 
HR (95% CI) 
 All subjects       
Never smoker 1 1 1 1 1  
Ex-smoker 0.97 (0.65-1.46) 1.20 (0.84-1.71) 0.77 (0.43-1.37) 1.23 (0.73-2.08) 0.79 (0.40-1.59) 0.64 (0.33-1.25) 
Quitters 1.15 (0.86-1.54) 1.03 (0.78-1.37) 0.71 (0.47-1.09) 0.90 (0.61-1.32) 0.62 (0.38-1.02) 0.69 (0.42-1.13) 
Persistent 2.12 (1.64-2.74) 1.99 (1.56-2.54) 1.46 (1.04-2.09) 0.94 (0.68-1.31) 0.70 (0.46-1.05) 0.74 (0.49-1.11) 
Unstructured 1.09 (0.71-1.67) 1.01 (0.67-1.52) 0.48 (0.22-1.06) 0.93 (0.52-1.68) 0.44 (0.18-1.08) 0.48 (0.20-1.15) 
       
Females       
Never-smoker 1 1 1 1 1 1 
Ex-smoker 0.75 (0.30-1.85) 1.55 (0.85-2.82) 1.12 (0.40-3.10) 2.06 (0.70-6.08) 1.48 (0.38-5.80) 0.72 (0.22-2.36) 
Quitters 1.10 (0.69-1.74) 0.93 (0.59-1.48) 0.55 (0.23-1.29) 0.85 (0.44-1.63) 0.50 (0.19-1.32) 0.59 (0.22-1.55) 
Persistent 1.97 (1.37-2.84) 1.94 (1.37-2.74) 1.67 (0.99-2.82) 0.98 (0.60-1.60) 0.84 (0.45-1.58) 0.86 (0.47-1.59) 
Unstructured 1.11 (0.64-1.91) 0.83 (0.47-1.49) 0.28 (0.07-1.17) 0.75 (0.34-1.67) 0.26 (0.06-1.17) 0.34 (0.07-1.57) 
       
Males       
Never smoker 1 1 1 1 1 1 
Ex-smoker 1.48 (0.69-3.15) 1.36 (0.70-2.64) 0.49 (0.21-1.15) 0.92 (0.34-2.50) 0.34 (0.11-1.03) 0.36 (0.13-1.06) 
Quitters 1.68 (0.84-3.36) 1.32 (0.72-2.43) 0.55 (0.27-1.09) 0.79 (0.31-1.97) 0.32 (0.12-0.86) 0.41 (0.17-1.04) 
Persistent 3.13 (1.60-6.12) 2.50 (1.39-4.49) 1.03 (0.54-1.95) 0.80 (0.33-1.95) 0.33 (0.13-0.83) 0.41 (0.17-0.98) 
Unstructured 1.48 (0.62-3.51) 1.46 (0.69-3.09) 0.51 (0.18-1.48) 0.99 (0.31-3.10) 0.35 (0.09-1.37) 0.35 (0.10-1.29) 
       
